NFE2L2 and Parkinson disease: EA enhances the Nrf2–ARE pathway and regulates the expression of antioxidants, such as the ARE-driven reporter gene, nicotinamide adenine dinucleotide phosphate quinone oxidoreductase, and heme oxygenase-1 (HO-1), thus relieving PD symptoms [166].